Stockreport

Phio Pharmaceuticals Announces Addition of Clinical Trial Site for its Phase 1b study of PH-762 [Yahoo! Finance]

Phio Pharmaceuticals Corp.  (PHIO) 
Last phio pharmaceuticals corp. earnings: 11/12 07:45 am Check Earnings Report
PDF Marlborough, Massachusetts--(Newsfile Corp. - July 8, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASY [Read more]